ArticleFrontiers in medicine2022

Short- and long-term follow-up and additional benefits in a sickle cell disease patient experienced severe crizanlizumab infusion-related vaso-occlusive crisis: A case report.

Awni Alshurafa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.